[EHA Special Lecture]Recent therapeutic algorithms in multiple myeloma
Pieter Sonneveld(Department of Hematology, Erasmus MC Cancer Institute, Netherlands)
The 80th Annual Meeting of the Japanese Society of Hematology
Oct 12 - Oct 14, 2018Osaka International Convention Center
You can search for presentations in this event.
Search
The 80th Annual Meeting of the Japanese Society of Hematology
Oct 12 - Oct 14, 2018Osaka International Convention Center
You can search for presentations in this event.
SearchSearch Results(1,598)
[SY1-1]Lymphoproliferative disorders and indolent lymphomas of B-cell origin
Elaine S. Jaffe(Hematopathology Section, Laboratory of Pathology, CCR, NCI, MD, USA)
[SY1-2]Lymphoproliferative disorders and indolent lymphomas of T/NK-cell origin
Kengo Takeuchi(Division of Pathology, Cancer Institute, JFCR, Japan)
[SY1-3]SMZL with HCV infection and indolent MCL
Hermine Olivier(Hematology, Paris Descartes University Imagine Institute, France)
[SY1-4]Understanding methotrexate-induced lymphoproliferative disorders from a clinical management perspective
Michihide Tokuhira, Masahiro Kizaki(Saitama Medical Center, Saitama Medical University, Japan)
[SY1-5]Clinical features of adult patients with chronic active Epstein-Barr virus infection; A distinct subtype of Epstein Barr virus positive T/NK cell lymphoproliferative disorder
Keisuke Kawamoto1, Hiroaki Miyoshi2, Masao Seto2, Hiroshi Kimura3, Koichi Ohshima2(1.Department of Hematology, Endocrinology, and Metabolism, Faculty of Medicine, Niigata University, Japan, 2.Department of Pathology, School of Medicine, Kurume University, Japan, 3.Department of Virology, Faculty of Medicine, Nagoya University, Japan)
[SY2-1]Functional diversity of the hematopoietic stem cell niche
Noboru Asada(Department of Hematology and Oncology, Okayama University, Okayama, Japan)
[SY2-2]A new role for CTCF as a gatekeeper of stemness in human hematopoietic stem cells
Naoya Takayama1,2, Alex Murison2, Shin-ichiro Takayanagi3(1.Department of Regenerative Medicine, Chiba University Graduate School of Medicine, Chiba, Japan, 2.Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada, 3.Regenerative Medicine Research Laboratories, R&D Division, Kyowa Hakko Kirin Co., Ltd., Japan)
[SY2-3]Understanding of bone marrow environment and hematopoietic stem cell regulation
Satoshi Yamazaki(The Institute of Medical Science, The University of Tokyo, Japan)
[SY2-4]Long-term single-cell quantification: New tools for old questions
Timm Schroeder(D-BSSE, Basel, ETH Zurich, Switzerland)
[SY2-5]Hematopoietics stem cells in stress, disease and aging (tentative)
Emmanuelle Passegué(Director, Columbia Stem Cell Initiative Alumni Professor of Genetics & Development (in Rehabilitation and Regenerative Medicine) Columbia University Medical Center, USA)
[EL1-3A]Transfusion of patients with autoimmune hemolytic anemia
Yasunori Ueda(Department of Hematology/Oncology, Kurashiki Central Hospital, Japan)
[EL1-3B]Treatment strategy for acquired aplastic anemia
Hirohito Yamazaki(Division of Transfusion Medicine, Kanazawa University Hospital, Japan)
[EL1-3C]A diagnostic approach to relatively common mild bleeding symptoms: screening of congenital mild bleeding disorders
Makoto Kaneko(Department of Laboratory Medicine, Tokyo Medical University Hospital, Japan)
[EL1-3D]Treatment of DIC associated with hematological malignancies
Yoshinobu Seki(Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan)
[EL1-4A]Clonal hematopoiesis in aplastic anemia
Hideki Makishima(Department of Pathology and Tumor Biology, Kyoto University, Japan)
[EL1-4B]Molecular pathophysiology of sideroblastic anemia
Tohru Fujiwara(Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Japan)
[EL1-4C]The principles and practice of research ethics
Chikara Hirase(Clinical Research Center, Kindai University Hospital, Japan)
[EL1-4D]Japanese Society of Hematology conflict of interest management in medical research
Naoyuki Katayama(Department of Hematology and Oncology, Mie University Graduate School of Medicine, Japan)
[EL1-6A]Clonal hematopoiesis and hematological malignancies
Toshio Kitamura(Institute of Medical Science, The University of Tokyo, Japan)
[EL1-6B]Molecular pathogenesis and treatment of core binding factor-acute myeloid leukemia
Yuichi Ishikawa(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Japan)
[EL1-6C]State-of-the-art treatment of acute promyelocytic leukemia
Toru Kiguchi(Chugoku Central Hospital, Japan)
[EL1-6D]Incorporation of novel agents into the treatment for acute myeloid leukemia
Takahiro Yamauchi(Department of Hematology and Oncology, University of Fukui, Japan)
[Presidential Lecture]Tyrosine kinase as a therapeutic target in hematologic malignancies
Itaru Matsumura(Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan)
[Special Lecture]Control of immune responses by regulatory T cells
Shimon Sakaguchi(Immunology Frontier Research Center, Osaka University, Japan)
[PSY-1]Molecular targeted therapy of acute myeloid leukemia
Hartmut Döhner(Department of Internal Medicine III, University Hospital of Ulm, Germany)
[PSY-2]Targeting BCL-2 in chronic lymphocytic leukemia and acute myeloid leukemia
Daniel A Pollyea1,2, Brett M Stevens1, Courtney L Jones1, Amanda Winters1, Shanshan Pei1, Mohammad Minhajuddin1, Angelo D'Alessandro1, Rachel Culp-Hill1, Kent A Riemondy1, Austin E Gillen1, Jay R Hesselberth1, Diana Abbott1, Derek Schatz1, Jonathan A Gutman1, Enkhtsetseg Purev1, Clayton Smith1, Craig T Jordan1(1.Division of Hematology, University of Colorado School of Medicine, United States of America, 2.University of Colorado School of Medicine, Division of Hematology, United States of America)
[PSY-3]Advancements in tyrosine kinase inhibitor therapy for chronic myeloid leukemia: a path to treatment-free remission
Naoto Takahashi(Hematol., Akita University, Akita, Japan)
[PSY-4]Cutting edge of molecular target therapy for Multiple Myeloma
Katja C Weisel(Hematology, Oncology and Immunology, University of Tuebingen, Germany)
[SY3-1]A bispecific antibody, emicizumab (HEMLIBRA), mimicking factor VIII: A novel alternative therapy for patients with hemophilia A with inhibitor
Keiji Nogami(Department of Pediatrics, Nara Medical University, Japan)
[SY3-2]Eculizumab for atypical HUS
Marie Ann Scully(Haematology, University College Hospital, UK)
[SY3-3]Rituximab for immune thrombocytopenia and thrombotic thrombocytopenic purpura
Yoshitaka Miyakawa(Thrombosis and Hemostasis Center, Saitama Medical University Hospital, Saitama, Japan)
[SY3-4]Caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura
Flora Peyvandi(Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Universit degli Studi di Milano, Italy)
[EL1-3E]Genetic aberrations and new treatment strategies for pediatric acute myeloid leukemia
Norio Shiba(Department of Pediatrics, Yokohama City University Graduate School of Medicine, Japan)
[EL1-3F]Genetic background and treatment of pediatric ALL
Motohiro Kato(Children's Cancer Center, National Center for Child Health and Development, Japan)
[EL1-3G]Therapeutic approaches to hematological malignancies in adolescents and young adults
Masahiro Sekimizu(Department of Pediatrics, National Hospital Organization, Nagoya Medical Center, Japan)
[EL1-3H]Chimeric antigen receptor T cell (CAR-T) therapy for refractory/relapsed hematological malignancy
Hidefumi Hiramatsu(Department of Pediatrics, Graduate School of Medicine Kyoto University, Japan)
[EL1-4E]Updated human hematopoietic stem cell findings: purification of human hematopoietic stem cells and elucidation of their hierarchy
Yoshiaki Sonoda(Department of Stem Cell Biology, Kansai Medical University, Japan)
[EL1-4F]Inflammation and early hematopoiesis
Hitoshi Takizawa(International Research Center for Medical Sciences, Kumamoto University, Japan)
[EL1-4G]Hematopoietic cell differentiation orchestrated by transcription factor network and its related pathogenesis
Kazuhiko Igarashi(Tohoku University Graduate School of Medicine, United Centers for Advanced Research and Translational Medicine (ART), Japan)
[EL1-4H]Niche signals regulate differentiation and functions of tissue resident macrophages
Daigo Hashimoto(Department of Hematology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan)
[EL1-6E]Revision of JSH Guideline for Tumors of Hematopoietic and Lymphoid Tissues 2018: lymphoma
Hirokazu Nagai(National Hospital Organization Nagoya Medical Center, Japan)
[EL1-6F]Treatment strategy for relapsed or refractory myeloma according to the new Guidelines
Shuji Ozaki(Department of Hematology, Tokushima Prefectural Central Hospital, Japan)
[EL1-6G]Cord blood transplantation for leukemia in nonremission
Naoyuki Uchida(Department of Hematology, Toranomon Hospital, Japan)
[EL1-6H]Introduction and the current status of unrelated peripheral blood stem cells transplantation in Japan
Koichi Miyamura(Department of Hematology, Japanese Red Cross Nagoya First Hospital, Japan)
[OS1-8A-4]Bone marrow histopathology and p53 expression in patients with Fanconi anemia
Nozomu Kawashima1, Masafumi Ito2, Asahito Hama1, Yusuke Okuno1, Hideki Muramatsu1, Shunsuke Miwata1, Kotaro Narita1, Shinsuke Kataoka1, Motoharu Hamada1, Norihiro Murakami1, Daiei Kojima1, Daisuke Ichikawa1, Kyogo Suzuki1, Hironobu Kitazawa1, Eri Nishikawa1, Rieko Taniguchi1, Atsushi Narita1, Nobuhiro Nishio1, Seiji Kojima1, Yoshiyuki Takahashi1(1.Pediatr., Nagoya Univ., Nagoya, Japan, 2.Pathol., JRC Nagoya First Hosp., Nagoya Japan)
[OS1-8A-1]Mutation analysis of GATA1 binding sites in ribosomal protein genes in Diamond-Blackfan anemia
Akie Kobayashi, Kaori Kubo, Rika Kanezaki, Tomohiko Sato, Kiminori Terui, Shinya Sasaki, Ko Kudo, Takuya Kamio, Tsutomu Toki, Etsuro Ito(Dept. Pediatrics, Hirosaki Univ., Japan)
[OS3-7C-3]Clinicopathological study of other iatrogenic immunodeficiency-associated LPD at Toranomon Hospital
Daisuke Kaji1,2, Michiho Ebihara1, Mitsuhiro Yuasa1, Kosei Kageyama1, Aya Nishida1, Shinsuke Takagi1, Hisashi Yamamoto1, Yuki Asano-Mori1, Naoyuki Uchida1, Yasunori Ota3, Koji Izutsu1,4, Shigeru Chiba5, Shuichi Taniguchi1, Go Yamamoto1(1.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 2.Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 3.Department of Pathology, The University of Teikyo, Tokyo, Japan, 4.Department of Hematology, National Cancer Center Hospital, Tokyo, Japan, 5.Department of Hematology, University of Tsukuba, Tsukuba, Japan)
[OS3-7D-4]Clinical analysis of post-transplantation lymphoproliferative disorders in Kyoto University Hospital
Mizuki Watanabe, Junya Kanda, Momoko Nishikori, Masakatsu Hishizawa, Tadakazu Kondo, Kouhei Yamashita, Akifumi Takaori-Kondo(Hematology and Oncology, Graduate School , Kyoto Univ, Kyoto, Japan)
[ASH Special Lecture]Advances in gene therapy for nonmalignant blood disorders
Alexis A Thompson(Pediatrics, Division of Hematology-Oncology, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University, United States of America)
1,598 results ( 1 - 50 )
- 1
- ...